Original-Research

Scandinavian Astor Group AB (von NuWays AG): BUY 14.04.2026, 09:00 Uhr von EQS Research Jetzt kommentieren: 0

Werte zum Artikel
Name Aktuell Diff. Börse
Scandinavian Astor Group 1,661 EUR +1,05 % L&S Exchange

Original-Research: Scandinavian Astor Group AB - from NuWays AG

14.04.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.


Classification of NuWays AG to Scandinavian Astor Group AB

Company Name: Scandinavian Astor Group AB
ISIN: SE0019175274
 
Reason for the research: Update
Recommendation: BUY
Target price: SEK 51
Target price on sight of: 12 months
Last rating change:
Analyst: Simon Keller

FY25 confirmed, Ammunity growth runway in focus

Astor closed FY25 with results fully in line with the preliminary figures released in February, leaving the financial picture unchanged. FY25 sales reached SEK 433m (+94% yoy), adj. EBITDA SEK 83m (margin: 19.2%, +6.3pp yoy), net cash SEK 35m and equity ratio 64%.

The year-end order backlog warrants brief context. While the figure may look modest at first glance, relative to some defence primes, lean firm backlogs are not unusual for suppliers of Astor's type, in our view. The clearest evidence is the 2024 starting point: the backlog due in 2025 stood at only SEK 135m, c. 39% of the SEK 345m in sales ultimately generated that year by the businesses already owned at the time (eNuW). Against that reference, the year-end 2025 backlog due in 2026 of SEK 409m, equivalent to c. 63% of our FY26e sales estimate of SEK 650m, reads as a step-up in visibility.

The management transition is a near-term overhang. Following the CFO change announced in January, Astor disclosed in April that CEO Mattias Hjorth will step down, with board member Martin Elovsson set to take over at the AGM on 13 May. The incoming CEO brings internal familiarity and an execution-focused background, which should support operational continuity. That said, any leadership transition carries execution risk, and we expect it to weigh on sentiment until the new team has established credibility with investors. For a group where the growth model is built on acquisitions, management continuity matters across capital allocation, integration discipline and external communication alike.

At the same time, the operational picture remains compelling. Astor is well-positioned across structurally growing defence end-markets, with demand tailwinds that show no signs of fading. The most interesting near-term growth vector is Ammunity, Latvia's only manufacturer of military small-calibre ammunition and the largest private ammunition producer in the Baltics, consolidated from Nov 25. Weeks after closing, Astor committed SEK 92m in capacity investment targeting additional production lines, with the potential to increase annual output up to sixfold over time and a first contribution to sales and profitability from this expansion is expected from H2 26.

The investment case for Ammunity rests on a highly favourable demand environment. Our analysis of Baltic defence procurement puts the annual addressable market for small-calibre ammunition only across Estonia, Latvia and Lithuania already at c. € 60m today. Against that backdrop, Ammunity's current revenue run-rate of c. € 13m (eNuW) already represents a meaningful share of a market that is itself expanding rapidly. As Latvia's sole domestic military-grade small-calibre producer, Ammunity carries a structural competitive advantage that few European peers can replicate. Sales expansion might also benefit from growth in Ukraine and the Nordic market.

Reiterate BUY, unchanged PT of SEK 51, based on a blend of DCF and peer group valuation.

You can download the research here: scandinavian-astor-group-ab-2026-04-14-update-en-6b79f
For additional information visit our website: https://www.nuways-ag.com/research-feed

Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben analysierten Unternehmen befindet sich in der vollständigen Analyse.
++++++++++


The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2307668  14.04.2026 CET/CEST

Kommentare (0) ... diskutiere mit.
Werbung

Handeln Sie Aktien bei SMARTBROKER+ für 0 Euro!* Profitieren Sie von kostenloser Depotführung, Zugriff auf 29 deutsche und internationale Börsenplätze und unschlagbar günstigen Konditionen – alles in einer innovativen, brandneuen App. Jetzt zu SMARTBROKER+ wechseln und durchstarten!

*Ab 500 EUR Ordervolumen über gettex. Zzgl. marktüblicher Spreads und Zuwendungen.

k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Weitere News
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer